Med Life (BSE:M) Change In Receivables : lei-82 Mil (TTM As of Dec. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Med Life Change In Receivables?

Med Life's change in receivables for the quarter that ended in Dec. 2024 was lei5 Mil. It means Med Life's Accounts Receivable declined by lei5 Mil from Sep. 2024 to Dec. 2024 .

Med Life's change in receivables for the fiscal year that ended in Dec. 2024 was lei-82 Mil. It means Med Life's Accounts Receivable increased by lei82 Mil from Dec. 2023 to Dec. 2024 .

Med Life's Accounts Receivable for the quarter that ended in Dec. 2024 was lei274 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Med Life's Days Sales Outstanding for the three months ended in Dec. 2024 was 33.91.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Med Life's liquidation value for the three months ended in Dec. 2024 was lei-2,122 Mil.

Med Life Change In Receivables Historical Data

The historical data trend for Med Life's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Med Life Change In Receivables Chart

Med Life Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Receivables

Get a 7-Day Free Trial

-37.48

-6.51

-36.11

-61.54

-82.36

Med Life Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Change In Receivables	Get a 7-Day Free Trial															-19.92	-34.86	7.00	-59.78	5.27

Med Life Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was lei-82 Mil.

Med Life (BSE:M) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Med Life's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	273.779	/	736.788	*	91
=	33.91

2. In Ben Graham's calculation of liquidation value, Med Life's accounts receivable are only considered to be worth 75% of book value:

Med Life's liquidation value for the quarter that ended in Dec. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	112.972	-	2515.054	+	0.75 * 273.779	+	0.5 * 148.578
=	-2,122

Med Life Change In Receivables Related Terms

Thank you for viewing the detailed overview of Med Life's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Med Life Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Med Life SA (BSE:M) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

Calea Grivitei, No. 365, District 1, Bucharest, ROU

Website

https://www.medlife.ro

Med Life SA is a healthcare provider in Romania. The Company's activity resides in the performance of healthcare services activities through medical centres with national coverage. It is engaged in the provision of rendering of medical services, rental of medical facilities and acquisition of materials and commodities. The company provides medical service through Hyper clinics in Arad, Bucharest, Braila, Brasov, Cluj, Constanta, Craiova, Galati, Iasi, Oradea, Ploiesti, Sibiu and Timisoara; Clinics, hospitals located in Bucharest, Arad, Sibiu, Brasov, Cluj and Ploiesti, Laboratories, Pharmacies and Dental Clinics.